The measurement of D,L-2,3-butanediol in controls and patients with alcoholic cirrhosis.

J P Casazza, J Freitas, D Stambuk, M Y Morgan, R L Veech
{"title":"The measurement of D,L-2,3-butanediol in controls and patients with alcoholic cirrhosis.","authors":"J P Casazza,&nbsp;J Freitas,&nbsp;D Stambuk,&nbsp;M Y Morgan,&nbsp;R L Veech","doi":"10.1300/J251v07n03_05","DOIUrl":null,"url":null,"abstract":"<p><p>Plasma D,L-2,3-butanediol was measured in 53 controls and 50 patients with alcoholic cirrhosis, none of whom had measurable amounts of blood ethanol. Thirteen of 50 samples from patients with alcoholic cirrhosis had measurable D,L-2,3-butanediol. (range less than 5-154 microM). In one patient with alcoholic cirrhosis who had been abstinent from ethanol for over 5 years plasma levels of D,L-2,3-butanediol ranged between 154 and 211 microM over a one-year period. Only one of the 53 control subjects had detectable levels of D,L-2,3-butanediol. Although it has previously been reported that 2,3-butanediol is present in alcoholics consuming distilled spirits (Rutstein et al. (1983) Lancet ii, 534), this is the first report of the persistent presence of these compounds in alcoholics in the absence of ethanol. Clearly in abstinent alcoholics the presence of 2,3-butanediol is not due to the ingestion of undistilled spirits nor is it likely to arise directly from the metabolic products of ethanol. The presence of D,L-2,3-butanediol in patients with alcoholic cirrhosis and its absence in control subjects suggests that this compound may be a marker of some forms for alcoholism.</p>","PeriodicalId":77481,"journal":{"name":"Advances in alcohol & substance abuse","volume":"7 3-4","pages":"33-5"},"PeriodicalIF":0.0000,"publicationDate":"1988-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1300/J251v07n03_05","citationCount":"3","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Advances in alcohol & substance abuse","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1300/J251v07n03_05","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 3

Abstract

Plasma D,L-2,3-butanediol was measured in 53 controls and 50 patients with alcoholic cirrhosis, none of whom had measurable amounts of blood ethanol. Thirteen of 50 samples from patients with alcoholic cirrhosis had measurable D,L-2,3-butanediol. (range less than 5-154 microM). In one patient with alcoholic cirrhosis who had been abstinent from ethanol for over 5 years plasma levels of D,L-2,3-butanediol ranged between 154 and 211 microM over a one-year period. Only one of the 53 control subjects had detectable levels of D,L-2,3-butanediol. Although it has previously been reported that 2,3-butanediol is present in alcoholics consuming distilled spirits (Rutstein et al. (1983) Lancet ii, 534), this is the first report of the persistent presence of these compounds in alcoholics in the absence of ethanol. Clearly in abstinent alcoholics the presence of 2,3-butanediol is not due to the ingestion of undistilled spirits nor is it likely to arise directly from the metabolic products of ethanol. The presence of D,L-2,3-butanediol in patients with alcoholic cirrhosis and its absence in control subjects suggests that this compound may be a marker of some forms for alcoholism.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
对照组和酒精性肝硬化患者D, l -2,3-丁二醇的测定。
对53名对照组和50名酒精性肝硬化患者的血浆D, l -2,3-丁二醇进行了测量,其中没有人的血液乙醇含量可测量。50例酒精性肝硬化患者样本中有13例检测到D, l -2,3-丁二醇。(量程小于5-154微米)。在一名酒精性肝硬化患者中,他戒酒5年以上,血浆中D, l -2,3-丁二醇的水平在一年内介于154 - 211微克之间。53名对照受试者中只有1人检测到D, l -2,3-丁二醇水平。虽然以前有报道称2,3-丁二醇存在于饮用蒸馏酒的酗酒者体内(Rutstein等人(1983)Lancet ii, 534),但这是首次报道在没有乙醇的情况下,这些化合物在酗酒者体内持续存在。显然,在戒酒者中,2,3-丁二醇的存在不是由于摄入未蒸馏的烈酒,也不可能直接从乙醇的代谢产物中产生。酒精性肝硬化患者体内存在D, l -2,3-丁二醇,而对照组中不存在D, l -2,3-丁二醇,这表明这种化合物可能是某些形式的酒精中毒的标志。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
Controlled Opiate Use Addictive behaviors and benzodiazepines: 2. Are there differences between benzodiazepines in potential for physical dependence and abuse liability? Drug dependence: defining the issues. Benzodiazepines: reconsidered. Addiction potential of benzodiazepines and non-benzodiazepine anxiolytics.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1